In trial I ( 1993-1995 ) , the mortality rate was 0.0 per 1000 person-years among children vaccinated with MV in the presence of maternal antibody and 32.3 per 1000 person-years without maternal antibody ( mortality rate ratio [ MRR ] , 0.0 ; 95 % confidence interval [ CI ] , 0 -.52 ) .